| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institut National de la Santé et de la Recherche Médicale, Unité 332, Institut Cochin de Genetique Moleculaire, Paris, France
As one of the initial mucosal transmission pathways of HIV (HIV-1), epithelial cells translocate HIV-1 from apical to basolateral surface by nondegradative transcytosis. Transcytosis is initiated when HIV-1 envelope glycoproteins bind to the epithelial cell membrane. Here we show that the transmembrane gp41 subunit of the viral envelope binds to the epithelial glycosphingolipid galactosyl ceramide (Gal Cer), an alternative receptor for HIV-1, at a site involving the conserved ELDKWA epitope. Disrupting the raft organization of the Gal Cer-containing microdomains at the apical surface inhibited HIV-1 transcytosis. Immunological studies confirmed the critical role of the conserved ELDKWA hexapeptide in HIV-1 transcytosis. Mucosal IgA, but not IgG, from seropositive subjects targeted the conserved peptide, neutralized gp41 binding to Gal Cer, and blocked HIV-1 transcytosis. These results underscore the important role of secretory IgA in designing strategies for mucosal protection against HIV-1 infection.
This article has been cited by other articles:
|
|
 |
|
  S. Bryson, J.-P. Julien, R. C. Hynes, and E. F. Pai Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications J. Virol., November 15, 2009; 83(22): 11862 - 11875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Arnold, P. K. Velasco, A. K. Holmes, T. Wrin, S. C. Geisler, P. Phung, Y. Tian, D. A. Resnick, X. Ma, T. M. Mariano, et al. Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope J. Virol., May 15, 2009; 83(10): 5087 - 5100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wright, M. E. Lamm, and Y. T. Huang Excretion of Human Immunodeficiency Virus Type 1 through Polarized Epithelium by Immunoglobulin A J. Virol., December 1, 2008; 82(23): 11526 - 11535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Coutant, H. Yu, M.-J. Clement, A. Alfsen, F. Toma, P. A. Curmi, and M. Bomsel Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1 FASEB J, December 1, 2008; 22(12): 4338 - 4351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Huang, Z. Qi, F. Wu, L. Kotula, S. Jiang, and Y.-H. Chen Interaction of HIV-1 gp41 Core with NPF Motif in Epsin: IMPLICATION IN ENDOCYTOSIS OF HIV J. Biol. Chem., May 30, 2008; 283(22): 14994 - 15002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Montero, N. E. van Houten, X. Wang, and J. K. Scott The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 54 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Muratori, A. Sistigu, E. Ruggiero, M. Falchi, I. Bacigalupo, C. Palladino, E. Toschi, and M. Federico Macrophages Transmit Human Immunodeficiency Virus Type 1 Products to CD4-Negative Cells: Involvement of Matrix Metalloproteinase 9 J. Virol., September 1, 2007; 81(17): 9078 - 9087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lewis, R. J. Pleass, M. R. Batten, J. D. Atkin, and J. M. Woof Structural Requirements for the Interaction of Human IgA with the Human Polymeric Ig Receptor J. Immunol., November 15, 2005; 175(10): 6694 - 6701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alfsen, H. Yu, A. Magerus-Chatinet, A. Schmitt, and M. Bomsel HIV-1-infected Blood Mononuclear Cells Form an Integrin- and Agrin-dependent Viral Synapse to Induce Efficient HIV-1 Transcytosis across Epithelial Cell Monolayer Mol. Biol. Cell, September 1, 2005; 16(9): 4267 - 4279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Schneeman, M. E. C. Bruno, H. Schjerven, F.-E. Johansen, L. Chady, and C. S. Kaetzel Regulation of the Polymeric Ig Receptor by Signaling through TLRs 3 and 4: Linking Innate and Adaptive Immune Responses J. Immunol., July 1, 2005; 175(1): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Buonaguro, M. L. Visciano, M. L. Tornesello, M. Tagliamonte, B. Biryahwaho, and F. M. Buonaguro Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation J. Virol., June 1, 2005; 79(11): 7059 - 7067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. T. Huang, A. Wright, X. Gao, L. Kulick, H. Yan, and M. E. Lamm Intraepithelial Cell Neutralization of HIV-1 Replication by IgA J. Immunol., April 15, 2005; 174(8): 4828 - 4835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Devito, B. Zuber, U. Schroder, R. Benthin, K. Okuda, K. Broliden, B. Wahren, and J. Hinkula Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity J. Immunol., December 1, 2004; 173(11): 7078 - 7089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Kang, L. Guo, Q. Yao, I. Skountzou, and R. W. Compans Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens J. Virol., September 15, 2004; 78(18): 9624 - 9632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Matoba, A. Magerus, B. C. Geyer, Y. Zhang, M. Muralidharan, A. Alfsen, C. J. Arntzen, M. Bomsel, and T. S. Mor A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs PNAS, September 14, 2004; 101(37): 13584 - 13589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, Y. Huang, R. Fayad, G. T. Spear, and L. Qiao Induction of Mucosal and Systemic Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) by Oral Immunization with Bovine Papillomavirus-HIV-1 gp41 Chimeric Virus-Like Particles J. Virol., August 1, 2004; 78(15): 8342 - 8348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Kang, Q. Yao, L. Guo, and R. W. Compans Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B J. Virol., September 15, 2003; 77(18): 9823 - 9830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Cummins Jr., J. M. Villanueva, T. Evans-Strickfaden, S. M. Sesay, S. R. Abner, T. J. Bush, T. A. Green, J. L. Lennox, T. Wright, T. M. Folks, et al. Detection of Infectious Human Immunodeficiency Virus Type 1 in Female Genital Secretions by a Short-Term Culture Method J. Clin. Microbiol., September 1, 2003; 41(9): 4081 - 4088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. I. Albu, A. Jones-Trower, A. M. Woron, K. Stellrecht, C. C. Broder, and D. W. Metzger Intranasal Vaccination Using Interleukin-12 and Cholera Toxin Subunit B as Adjuvants To Enhance Mucosal and Systemic Immunity to Human Immunodeficiency Virus Type 1 Glycoproteins J. Virol., May 15, 2003; 77(10): 5589 - 5597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wolbank, R. Kunert, G. Stiegler, and H. Katinger Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12 J. Virol., April 1, 2003; 77(7): 4095 - 4103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-L. Waarts, R. Bittman, and J. Wilschut Sphingolipid and Cholesterol Dependence of Alphavirus Membrane Fusion. LACK OF CORRELATION WITH LIPID RAFT FORMATION IN TARGET LIPOSOMES J. Biol. Chem., October 4, 2002; 277(41): 38141 - 38147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. van Meer and Q. Lisman Sphingolipid Transport: Rafts and Translocators J. Biol. Chem., July 12, 2002; 277(29): 25855 - 25858. [Full Text] [PDF]
|
|
|
|
|
|
A. Alfsen and M. Bomsel HIV-1 gp41 Envelope Residues 650-685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide J. Biol. Chem., July 5, 2002; 277(28): 25649 - 25659. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
